Evogliptin
(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
Molecular Identity
Evogliptin
(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
PubChem CID: 25022354
2D Structure
Properties
C19H26F3N3O3
Molecular Formula
401.40
Molecular Weight
g/mol
401.1926
Exact Mass
Da
1
XLogP
Drug-like (Lipinski: < 5)
84.7
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
558
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Evogliptin1222102-29-5evogliptinaevogliptineDA122909118300L7(R)-4-((R)-3-Amino-4-(2,4,5-trifluorophenyl)-butanoyl)-3-(t-butoxymethyl)-piperazin-2-one2-Piperazinone, 4-((3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-3-((1,1-dimethylethoxy)methyl)-, (3R)-DTXSID001535452-Piperazinone, 4-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-3-[(1,1-dimethylethoxy)methyl]-, (3R)-evogliptinumRefChem:139681DTXCID1076036A10BH07(3R)-4-((3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-((tert-butoxy)methyl)piperazin-2-one
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Evogliptin
Loading drug network...